Telomerase-specific replication-selective virotherapy combined with radiation therapy for oral squamous cell carcinoma cells

被引：0
|
作者：
Kurihara, Yuji [1 ]
Sato, Daisuke [1 ]
Shirota, Tatsuo [1 ]
Kondo, Seiji [1 ]
Kataoka, Masafumi [2 ]
Urata, Yasuo [3 ]
Fujiwara, Toshiyoshi [4 ]
Shintani, Satoru [1 ]
机构：
[1] Showa Univ, Sch Dent, Tokyo 142, Japan
[2] Okayama Univ, Grad Sch, Dept Surg, Okayama 7008530, Japan
[3] Oncolys BioPharma Inc, Tokyo, Japan
[4] Okayama Univ, Grad Sch Med & Dent, Dept Surg, Div Surg Oncol, Okayama 7008530, Japan
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-4976
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4976
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Combined Oncolytic Virotherapy with Herpes Simplex Virus for Oral Squamous Cell Carcinoma
    Ogawa, Fumi
    Takaoka, Hiroo
    Iwai, Soichi
    Aota, Keiko
    Yura, Yoshiaki
    ANTICANCER RESEARCH, 2008, 28 (6A) : 3637 - 3645
  • [22] Oncolytic virotherapy for oral squamous cell carcinoma using replication-competent viruses
    Saito, Kengo
    Shirasawa, Hiroshi
    Isegawa, Naohisa
    Shiiba, Masashi
    Uzawa, Katsuhiro
    Tanzawa, Hideki
    ORAL ONCOLOGY, 2009, 45 (12) : 1021 - 1027
  • [23] Combined effects of the cepharanthine and radiation on human oral squamous cell carcinoma cells
    Harada, T.
    Harada, K.
    Ueyama, Y.
    ORAL ONCOLOGY, 2011, 47 : S134 - S134
  • [24] Comments on "Oncolytic virotherapy for oral squamous cell carcinoma using replication-competent viruses"
    Raja, Kannan
    ORAL ONCOLOGY, 2024, 155
  • [25] Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells
    Watanabe, T
    Hioki, M
    Fujiwara, T
    Nishizaki, M
    Kagawa, S
    Taki, M
    Kishimoto, H
    Endo, Y
    Urata, Y
    Tanaka, N
    Fujiwara, T
    EXPERIMENTAL CELL RESEARCH, 2006, 312 (03) : 256 - 265
  • [26] Potent antitumor effects of combined therapy with a telomerase-specific, replication-competent adenovirus (OBP-301) and IL-2 in a mouse model of renal cell carcinoma
    Huang, P.
    Kaku, H.
    Chen, J.
    Kashiwakura, Y.
    Saika, T.
    Nasu, Y.
    Urata, Y.
    Fujiwara, T.
    Watanabe, M.
    Kumon, H.
    CANCER GENE THERAPY, 2010, 17 (07) : 484 - 491
  • [27] Potent antitumor effects of combined therapy with a telomerase-specific, replication-competent adenovirus (OBP-301) and IL-2 in a mouse model of renal cell carcinoma
    P Huang
    H Kaku
    J Chen
    Y Kashiwakura
    T Saika
    Y Nasu
    Y Urata
    T Fujiwara
    M Watanabe
    H Kumon
    Cancer Gene Therapy, 2010, 17 : 484 - 491
  • [28] Combined surgery and radiation therapy for squamous cell carcinoma of the hypopharynx
    Kraus, DH
    Zelefsky, MJ
    Brock, HAJ
    Huo, J
    Harrison, LB
    Shah, JP
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1997, 116 (06) : 637 - 641
  • [29] Selective ablation of human cancer cells by telomerase-specific adenoviral suicide gene therapy vectors expressing bacterial nitroreductase
    Alan E Bilsland
    Claire J Anderson
    Aileen J Fletcher-Monaghan
    Fiona McGregor
    T R Jeffry Evans
    Ian Ganly
    Richard J Knox
    Jane A Plumb
    W Nicol Keith
    Oncogene, 2003, 22 : 370 - 380
  • [30] Squamous-cell carcinoma of the penis: Radiation therapy alone or combined surgery and radiation therapy?
    Ozsabin, M
    Jichlinski, P
    Weber, D
    Azria, D
    Guillou, L
    Mirimanoff, RO
    Zouhair, A
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 102 - 102
12345